Chronic complications, cardiovascular risk factors and HbA1c values in type 1 diabetes mellitus 14 years after diagnosis;Complicaciones crónicas, factores de riesgo cardiovascular y HbA1c en la diabetes mellitus tipo 1 a los 14 años de diagnostico

Endocrinologia y Nutricion

Volumn 52, Issue 9, 2005, Pages 484-492

  Martinez Riquelme A ^a,b   Castell, C ^a   Mabres, C ^a   Lara, M ^a  

^a Associació Catalana de Diabetes y Consell Assesor para la Diabetes en Cataluña   (Spain)

^b NONE   (Spain)

Author keywords

HbA1c; Microvascular complications; Type 1 diabetes mellitus

Indexed keywords

CARDIOVASCULAR RISK; CLINICAL EXAMINATION; DIABETES MELLITUS; DISEASE ASSOCIATION; EVALUATION; HEART FUNCTION; HUMAN; MEDICAL RECORD; MICROALBUMINURIA; PREVALENCE; RETINOGRAPHY; REVIEW; RISK ASSESSMENT; STANDARDIZATION;

EID: 28844475635     PISSN: 15750922     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1575-0922(05)71048-2     Document Type: Article

References (75)

1. DCCT Research Group: the effect of intensive diabetes treatment on the development and progression of long-term complications in insulin-dependent diabetes mellitus: the Diabetes Control and Complications Trial. New Eng J Med 1993;329:977-86.
2. DCCT Research Group: prevention of neuropathy. The effect of intensive diabetes therapy on the development and progression of neuropathy in the DCCT. Ann Intern Med 1995;22:564-8.
3. DCCT Research Group: effect of intensive therapy on the development of nephropathy in the DCCT. Kidney Int 1995;47:1703-20.
4. DCCT Research Group: the effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependant diabetes mellitus. Arch Ophthalmol 1995;113:36-51.
5. DCCT Research Group: the effect of intensive diabetes management on macro-vascular events and risk factors in the DCCT. Am J Cardiol 1995;75:894-903.
6. The epidemiology of Diabetes Interventions and Complications (EDIC): design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial. Diabetes Care 1999;22:99-111.
7. Mühlhauser I, Overmann H, Bender R, Jörgens V, Berger M. Predictors of mortality and end-stage diabetic complications in patients with type 1 diabetes mellitus on insulin therapy. Diabet Med 2000;17:727-34.
8. Weis U, Turner B, Gibney J, Watts GF, Burke V, Shaw KM, et al. Long-term predictors of coronary artery disease and mortality in type 1 diabetes. Q J Med. 2001;94:623-30.
9. Mühlhauser I, Overmann H, Bender R, Bott U, Jörgens V, Grüsser M, et al. Cigarette smoking and progression of retinopathy and nephropathy in Type 1 diabetes. Diabet Med. 1996;13:536-43.
10. Esmatjes E, De Alvaro F. Incidence of diabetic nephropathy in type 1 diabetic patients in Spain: "Estudio Diamante". Diabetes Res Clin Pract. 2002;57:35-43.
11. Hovind P, Rossing P, Tarnow L, Parving H. Smoking and progression of diabetic nephropathy in type 1 diabetes. Diabetes Care. 2003;26:911-6.
12. Scott LJ, Warran JH, Hanna LS, Laffel LMB, Ryan L, Krolewski AS. A nonlinear effect of hyperglycemia and current cigarette smoking are major determinants of the onset of microalbuminuria in Type 1 Diabetes. Diabetes. 2001;50:2842-9.
13. European IDDM Policy Group 1993. Consensus guidelines for the management of insulin-dependent (Type 1) diabetes. Diabet Med. 1993;10:990-1005.
14. Mogensen CE, Schmilz O. The diabetic kidney: from hyperfiltration and microalbuminuria to end-stage renal failure. Med Clin North Am. 1988;72:1465-92.
15. Viberti GC, Bilous RW, Mackintosh D, Keen H. Monitoring glomerular function in diabetic nephropathy: a prospective study. Am J Med. 1983;74:256-64.
16. Bakker AJ. Detection of microalbuminuria. Receiver operating characteristic curve analysis favors albumin-to-creatinine ratio over albumine concentration. Diabetes Care. 1999;22:307-13.
17. Retinopathy Working Party. A protocol for screening for diabetes retinopathy in Europe. Diabetic Med. 1991;8:263-7.
18. Aldington SJ, Kohner EM, Meuer S, Klein R, Sjolie AK. Methodology for retinal photography and assessment of diabetic retinopathy: the EURODIAB IDDM Complications Study. Diabetologia. 1995;38:437-44.
19. Feldman EL, Stevens MJ, Thomas PK, Brown MB, Canal N, Greene DA. A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care. 1994;17:1281:9.
20. Dyck PJ. Detection, characterization and staging of polyneuropathy: assessed in diabetics. Muscle Nerve. 1988;11:21-32.
21. Perkins BA, Olaleye D, Zinman B, Bril V. Simple screening test for peripheral neuropathy in the diabetes clinic. Diabetes Care. 2001;24:250-6.
22. American Diabetes Association and American Academy of Neurology. Report and recommendations of the San Antonio Conference on diabetic neuropathy. Diabetes Care. 1988;11:592-7.
23. Ewing DJ, Clarke BF. Diabetic autonomic neuropathy: a clinical viewpoint. En: Dyck PJ, Thomas PK, Asbury AK, Winegrad AI, Porte D, editor. Diabetic Neuropathy. Philadelphia: Saunders; 1987.
24. Vespasiani G, Bruni M, Meloncelli I, Clementi L, Amoretti R, Branca S, et al. Validation of a computerised measurement system for guided routine evaluation of cardiovascular autonomic neuropathy. Comp Meth Prog Biom. 1996;51:211-6.
25. Krolewski AS, Laffel LMB, Krolewski M, Quinn M, Warram JH. Glycosilated hemoglobin and risk of microalbuminuria in patients with insulindependent diabetes mellitus. N Engl J Med. 1995;332:1251-5.
26. Warram JH, Gearin G, Laffel L, Krolewski AS. Effect of duration of type 1 diabetes in the prevalence of stages of diabetic nephropathy defined by albumin/creatinin ratio. J Am Soc Nephrol. 1996;7:930-7.
27. Krolewski M, Eggers P, Warram JH. Magnitude of end-stage renal disease in IDDM: a 35-year follow-up study. Kidney Int. 1996;50:2041-6.
28. Amos AF, McCarty DJ, Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med. 1997;14:S7-S185.
29. Esmatjes E, Castell C, Goday A, Montanya E, Pou JM, Salinas I, et al. Prevalencia de nefropatía en la diabetes mellitus tipo I. Med Clin (Barc). 1998;1:6-10.
30. Parving HH, Hommel E, Mathiesen E, Skøtt P, Edsberg B, Bahnsen M, et al. Prevalence of microalbuminuria, arterial hypertension, retinopathy and neuropathy in patients with insulin dependent diabetes. Br Med J. 1988;1:156-60.
31. Harvey JN, Rizvi K, Craney L, Messenger J, Shah R, Meadows PA. Population- based survey and analysis of trends in the prevalence of diabetic nephropathy in Type 1 diabetes. Diabet Med. 2001;18:998-1002.
32. Mangili R, Deferrari G, Di Mario U, Giampietro O, Navalesi R, Nosadini R, et al. Arterial hipertension and microalbuminuria in IDDM: the Italian Microalbuminuria Study. Diabetologia. 1994;37:1015-24.
33. Krolewski AS, Warram JH, Christlieb AR, Busick EJ, Khan CR. The changing natural history on nephropathy in type 1 diabetes. Am J Med. 1985;78:785-94.
34. Janner M, Snill SE, Diem P, Zuppinger KA, Mullis PE. Persistent microalbuminuria in adolescents with type 1 diabetes mellitus is associated to early rather than late puberty -results of a prospective longitudinal study. Eur J Pediatr. 1994;153:403-8.
35. Bognetti E, Calori G, Meschi F, Macellaro P, Bonifanti R, Ghiumello G. Prevalence and correlations of early microvascular complications in young type 1 diabetic patients: role of puberty. J Pediatr Endocrinol Metab. 1997;10:587-92.
36. Bojestij M, Arnqvist HJ, Hermansson G, Kalberg BE, Ludvigsson J. Declining incidence of nephropathy in type 1 diabetes mellitus. N Engl J Med. 1994;330:15-8
37. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy (II). Prevalence and risk of retinopathy when age at diagnostis is less than 30 years. Arch Ophthalmol. 1984;102:520-6.
38. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy (IX). Four year incidence and progression of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol. 1989;107:237-44.
39. Klein R, Klein BEK, Moss SE, Cruickshanks KJ. The Wisconsin Epidemiologic Study of Diabetic Retinopathy (XIV). Ten-year incidence and progression of diabetic retinopathy. Arch Ophthalmol. 1994;113:702-3.
40. Klein R, Klein BEK, Moss SE, Cruickshanks KJ. The Wisconsin Epidemiologic Study of Diabetic Retinopathy (XV). The long-term incidence of macular edema. Ophthalmology. 1995;102:7-16.
41. Krolewski AS, Warram JH, Rand Li, Christlieb AR, Busick EJ, Khan CR. Risk of proliferative retinopathy in juvenile-onset type 1 diabetes mellitus: a 40-year follow-up study. Diabetes Care. 1986;9:443-52.
42. Lövestam-Adrian M, Agardh E, Agardh CD. The temporal development of retinopathy and nephropathy in type 1 diabetes mellitus during 15 years diabetes duration. Diabet Res Clin Pract. 1999;45:15-23.
43. Lövestam-Adrian M, Agardh CD, Torffvit O, Agardh E. Diabetic retinopathy, visual acuity, and medical risk indicators. A continuous 10-year follow-up study in type 1 diabetic patients under routine care. J Diabet Compl. 2001;15:287-94.
44. Kullberg CE, Arnqvist HJ. Good blood glucose control characterizes patients without retinopathy after long diabetes duration. Diabet Med. 1995;12:314-20.
45. Porta M, Sjoelie AK, Chaturvedi N, Stevens L, Rottiers R, Veglio M, et al, and the EURODIAB Prospective Complications Study Group. Risk factors for progression to proliferative retinopathy in the EURODIAB Prospective Complications Study. Diabetologia. 2001;44:2203-9.
46. Service FJ, O'Brien PC. The relation of glycaemia to the risk of development and progression of retinopathy in the Diabetic Control and Complication Trial. Diabetologia. 2001;44:1215-20.
47. The Diabetes Control and Complications Trial Research Group. The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial. Diabetes. 1996;45:1289-98.
48. Pirart J. Diabetes mellitus and its degenerative complications: a prospective study of 44,000 patients observed between 1947 and 1973. Diabetes Care. 1979;1:168-88.
49. Boulton AJM, Knight G, Drury J, Ward JD. The prevalence of symptomatic diabetic neuropathy in an insulin-treated population. Diabetes Care. 1985;8:125-8.
50. MacLeod AF, Williams DR, Sonksen PH. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia. 1993;36:150-4.
51. Fedele D, Comi G, Coscelli C, Cucinotta D, Feldman EL, Ghirlanda G, et al. A multicenter study of the prevalence of diabetic neuropathy in Italy. Italian Diabetic Neuropathy Committee. Diabetes Care. 1997;20:836-43.
52. Cabezas-Cerrato and the Neuropathy Spanish study Group of the Spanish Diabetes Society. The prevalence of clinical diabetic polyneuropathy in Spain: a study in primary care and hospital clinic groups. Diabetologia. 1998;41:1263:9.
53. nd ed. Oxford: Blackwell; 1997.
54. nd ed. Oxford: Blackwell; 1997.
55. Franklin GM, Khan LB, Baxter J, Marshall JA, Hamman RF. Sensory neuropathy in non-insulin dependent diabetes mellitus. The San Luis Valley Diabetes study. Am J Epidemiol. 1990;131:633-43.
56. Young MJ, Boulton AJM, MacLeod AF, Williams DRR, Uusitupa Sonksen PH. A multicentre study of prevalence of diabetic neuropathy in United Kingdom hospital clinic population. Diabetologia. 1993;36:150-4.
57. Bao X, Wong V, Wang Q, Low LCK. Prevalence of peripheral neuropathy with insulin-dependent diabetes mellitus. Pediatr Neurol. 1999;20:204-9.
58. Neil HAW. The epidemiology of diabetic autonomic neuropathy. En: Bannister R, Mathias CJ, editors. Autonomic failure. A textbook of clinical disorders of the autonomic nervous system. Oxford: Oxford University Press; 1992. p. 682-97.
59. Karavanaki K, Davies AG, Morgan MH, Baum JD. Autonomic function in a cohort of children with diabetes. J Pediatr Endocrinol Metab. 1997;10:599-607.
60. Donahue KC. Autonomic neuropathy: diagnosis and impact on health in adolescents with diabetes. Horm Res. 1998;50 Suppl 1:33-7.
61. Karavanaki-Karanassiuo K. Autonomic neuropathy in children and adolescents with diabetes mellitus. J Pediatr Endocrinol Met. 2001;14 Suppl 5:1379-86.
62. Pfeifer MA, Weinberg CR, Cook DL, Reenan A, Halter JB, Ensick JW, et al. Autonomic neural dysfunction in recently diagnosed diabetes subjects. Diabetes Care. 1984;7:447-53.
63. Flynn MD, O'Brien IA, Corral RJ. The prevalence of autonomic and peripheral neuropathy in insulin-treated diabetic subjects. Diabet Med. 1995;12:310-3.
64. Levitt NS, Stansberry KB, Wynchank S, Vinik AI. The natural progression of autonomic neuropathy and autonomic function tests in a cohort of people with IDDM. Diabetes Care. 1996;7:751-4.
65. May O, Arildsen H, Damsgaard EM, Mickley H. Cardiovascular autonomic neuropathy in insulindependent diabetes mellitus: prevalence and estimated risk of coronary heart disease in the general population. J Int Med. 2000;248:483-91.
66. Kempler P, Tesfaye S, Chaturvedi N, Stevens LK, Webb DJ, Eaton S, et al. Blood pressure response to standing in the diagnosis of autonomic neuropathy: the EURODIAB IDDM Complications Study. Arch Physiol Biochem. 2001;109:215-22.
67. O'Brien IAD, Corral RJM. Epidemiology of diabetes and its complication. N Engl J Med. 1988;318:1619-20.
68. Neil HAW, Thompson AV, John S, McCarthy ST, Mann JI. Diabetic autonomic neuropathy: the prevalence of impaired rate variability in a geographically defined population. Diabetic Med. 1989;6:20-4.
69. Ziegler D, Gries FA, Spüler M, Lessmann F, and the DiaCAN Multicenter Study Group. The epidemiology of diabetic neuropathy. Diabetic Med. 1993;10 Suppl 2:82S-6S.
70. Mølgaard H, Christensen PD, Sørensen KE, Christensen CK, Mogensen CE. Association of 24-h cardiac parasympathetic activity and degree of nephropathy in IDDM. Diabetes. 1992;41:812-7.
71. Torffit O, Lindqvist A, Agardh CD, Pahlm O. The association between diabetic nephropathy and autonomic nerve function in type 1 diabetic patients. Scand J Clin Lab Invest. 1997;57:183-92.
72. Clarke CF, Eason M, Reilly A, Boyce D, Werther GA. Autonomic nervous function in adolescents with type 1 diabetes mellitus: relationship to microalbuminuria. Diabetic Medicine. 1999;16:550-4.
73. Stella P, Ellis D, Maser RE, Orchard TJ. Cardiovascular autonomic neuropathy (expiration and inspiration ratio) in type 1 diabetes. Incidence and predictors. J Diabetes Complications. 2000;14:1-6.
74. Koivisto VA, Stevens LK, Mattock M, Ebeling P, Muggeo M, Stephenson J, et al. Cardiovascular disease and its risk factors in IDDM in Europe. Diabetes Care. 1996;19:689-97.
75. Omar M, Asmal A. Complications of early-onset insulin-dependent diabetes mellitus in blacks and indians. S Afr Med J. 1984;65:75-8.